Help Stop Glenn Bullman’s Multiple Sclerosis
Everyone should have a friend like Glenn Bullman.
Kind, compassionate, and always willing to lend an ear, this devoted family man is everybody’s friend. And now he desperately needs the help of all his friends, old and new.
Glenn is battling Primary Progressive Multiple Sclerosis (PPMS). It’s one of four types of MS and is the more difficult one to treat, with only one FDA-approved drug.
With every passing day, the disease continues to wear down Glenn’s body.
Mundane tasks that were once so simple — putting on shoes, taking out the trash, planting flowers in the garden — are now a challenge. And fatigue and pain are his constant companions.
His most frustrating symptoms are “drop foot” and weakness in his left leg, which cause his left foot to drag and also affect hip function. The progression of these symptoms has required Glenn to use a walking stick to help with balance and avoid tripping. Still, falls are becoming a more regular occurrence.
Without a revolutionary medical treatment, further progression of Glenn’s disease is pointing to life in a wheelchair.
The medical community here in the U.S. believes that stem cell interventions hold the answers for breakthroughs in MS treatment. But the snail pace of approved research has put our country behind others when it comes to developing such treatments.
And while there are studies under way at notable medical institutions here in the states, they are either in trial stages or only for non-PPMS patients.
The good news is that doctors in Israel are having success treating PPMS patients like Glenn with Hematopoietic Stem Cell Transplantation (HSCT) — a therapy currently used in the states to treat leukemia and other forms of cancer. HSCT attempts to “reboot” the immune system, which is responsible for causing the damage.
In a nutshell, healthy stem cells are drawn from the patient’s bone marrow or blood. Then the patient’s damaged immune system is virtually shut down via powerful drugs. Finally, the stem cells are infused intravenously, effectively giving the patient a brand-new immune system.
Many patients undergoing this treatment have seen the progression of their PPMS come to a halt. And Glenn has been given the green light to receive the therapy in Israel!
But the cost of the HSCT procedure is $120,000. And insurance doesn’t pay a dime.
Glenn and his lovely wife Kristin would never ask for help. So, we’re rallying friends on their behalf to raise the funds needed to pay for this life-changing treatment. Will you please join us?
Our total goal is to raise $148,500 by February 28. This will cover the treatment and additional expenses such as travel, 2-month’s apartment rental near the hospital, groceries and a personal caregiver to be with Glenn at all times (required by the hospital).
With your help, Glenn will undergo this game-changing procedure in the spring and be back and feeling strong in time for his son’s college graduation.
Please donate whatever you can, and help Glenn reclaim his life. Thank you so much!
Everyone should have a friend like Glenn Bullman.
Kind, compassionate, and always willing to lend an ear, this devoted family man is everybody’s friend. And now he desperately needs the help of all his friends, old and new.
Glenn is battling Primary Progressive Multiple Sclerosis (PPMS). It’s one of four types of MS and is the more difficult one to treat, with only one FDA-approved drug.
With every passing day, the disease continues to wear down Glenn’s body.
Mundane tasks that were once so simple — putting on shoes, taking out the trash, planting flowers in the garden — are now a challenge. And fatigue and pain are his constant companions.
His most frustrating symptoms are “drop foot” and weakness in his left leg, which cause his left foot to drag and also affect hip function. The progression of these symptoms has required Glenn to use a walking stick to help with balance and avoid tripping. Still, falls are becoming a more regular occurrence.
Without a revolutionary medical treatment, further progression of Glenn’s disease is pointing to life in a wheelchair.
The medical community here in the U.S. believes that stem cell interventions hold the answers for breakthroughs in MS treatment. But the snail pace of approved research has put our country behind others when it comes to developing such treatments.
And while there are studies under way at notable medical institutions here in the states, they are either in trial stages or only for non-PPMS patients.
The good news is that doctors in Israel are having success treating PPMS patients like Glenn with Hematopoietic Stem Cell Transplantation (HSCT) — a therapy currently used in the states to treat leukemia and other forms of cancer. HSCT attempts to “reboot” the immune system, which is responsible for causing the damage.
In a nutshell, healthy stem cells are drawn from the patient’s bone marrow or blood. Then the patient’s damaged immune system is virtually shut down via powerful drugs. Finally, the stem cells are infused intravenously, effectively giving the patient a brand-new immune system.
Many patients undergoing this treatment have seen the progression of their PPMS come to a halt. And Glenn has been given the green light to receive the therapy in Israel!
But the cost of the HSCT procedure is $120,000. And insurance doesn’t pay a dime.
Glenn and his lovely wife Kristin would never ask for help. So, we’re rallying friends on their behalf to raise the funds needed to pay for this life-changing treatment. Will you please join us?
Our total goal is to raise $148,500 by February 28. This will cover the treatment and additional expenses such as travel, 2-month’s apartment rental near the hospital, groceries and a personal caregiver to be with Glenn at all times (required by the hospital).
With your help, Glenn will undergo this game-changing procedure in the spring and be back and feeling strong in time for his son’s college graduation.
Please donate whatever you can, and help Glenn reclaim his life. Thank you so much!
Fundraising team: Friends of Glenn Bullman10
Glenn Bullman
Beneficiary